Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis

BACKGROUND: Rituximab is a promising steroid sparing agent used in the treatment of moderate to severe pemphigus vulgaris. Its exact place in the algorithm of pemphigus treatment, vis-à-vis other, conventional adjuvant therapy (CAT) is not known. OBJECTIVE: To describe and compare disease course out...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Ashwin, Hall, Russell P., Bañez, Lionel L., Cardones, Adela R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155499/
https://www.ncbi.nlm.nih.gov/pubmed/30252855
http://dx.doi.org/10.1371/journal.pone.0198074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155499/
https://www.ncbi.nlm.nih.gov/pubmed/30252855
http://dx.doi.org/10.1371/journal.pone.0198074

Ejemplares similares